Stryker completes acquisition of Amplitude Vascular Systems
The deal adds next-generation intravascular lithotripsy technology to Stryker's peripheral vascular portfolio. Announced from Portage, Mich.
See the latest news and media coverage for Stryker. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company
stryker.comLast updated
In short: Stryker expanded its orthopedic and vascular portfolios through the $835 million acquisition of AVS while recovering from a major March cyberattack.
The deal adds next-generation intravascular lithotripsy technology to Stryker's peripheral vascular portfolio. Announced from Portage, Mich.
Results reflect operational challenges but strong fundamentals and healthy demand. The company remains confident in financial commitments.
Net sales rose 2.6% to $6.0B. Organic growth was 2.4%. Adjusted EPS fell 8.5% to $2.60. Maintains full-year guidance.
The deal adds next-generation IVL technology to strengthen Stryker’s peripheral vascular portfolio for treating calcified arterial disease.
With a short percentage of shares outstanding of 1.63%, Stryker Corporation (NYSE:SYK) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June...
On June 17, 2026, Stryker Corp SYK shares fell 3.0% today, bringing the current price to $301.14. GF Score™ of 92/100 indicates a strong overall...
The Federal Circuit on Wednesday agreed with a lower court decision rejecting Boston Scientific Corp.'s request to temporarily block Stryker Corp. from launching a back...
Boston Scientific Corp. couldn't convince the Federal Circuit to reverse a district court and block the launch of a competitor's surgical device used for a...
Track Stryker and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Stryker and other trending companies.